Phase II trial of imatinib mesylate in patients with metastatic melanoma

K. B. Kim, O. Eton, D. W. Davis, M. L. Frazier, D. J. McConkey, A. H. Diwan, N. E. Papadopoulos, A. Y. Bedikian, L. H. Camacho, M. I. Ross, J. N. Cormier, J. E. Gershenwald, J. E. Lee, P. F. Mansfield, L. A. Billings, C. S. Ng, C. Charnsangavej, M. Bar-Eli, M. M. Johnson, A. J. MurgoV. G. Prieto

Research output: Contribution to journalArticlepeer-review

159 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of imatinib mesylate in patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences